Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
This non-discretionary sale tied to restricted stock unit vesting reduced the CFO's direct holdings by 3%, though he retains a $12.1 million equity stake in the healthcare platform operator.
Overview
Matthew Sonefeldt, the chief financial officer of Doximity, Inc. (NYSE:DOCS), reported a non-discretionary disposition of 15,311 shares of Class A Common Stock on August 15, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($24.80).
Details
Doximity is a leading digital health platform serving the U.S. healthcare practitioner community with approximately 880 employees and a market capitalization of $4.6 billion. The company has achieved substantial profitability with TTM net income of $167.0 million on revenue of $655.6 million, demonstrating strong unit economics and operational efficiency. Doximity's competitive advantage derives from its comprehensive practitioner network, integrated suite of clinical and professional tools, and established relationships with pharmaceutical and healthcare organization customers.
Source
Originally published at www.fool.com.